Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about TAK
Recent news which mentions TAK
< Previous
1
2
3
4
5
6
7
8
Next >
Takeda's Breakthrough Blood Cancer Drug Flunks In Phase 3 Study
September 02, 2021
Tickers
TAK
TKPHF
Tags
Trading Ideas
Briefs
FDA
From
Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
Tickers
ABBV
ADGI
ASMB
AXNX
Tags
FULC
Benzinga
CCEL
From
Benzinga
Moderna Japan Scare Might Offer a Small Lift to Still-Alive Novavax Stock
September 02, 2021
Tickers
MRNA
NVAX
PFE
TAK
Tags
Market News
PFE
TAK
From
InvestorPlace
Moderna Reviews Contamination In Vaccine Lot Distributed In Japan
September 01, 2021
Tickers
MRNA
TAK
Tags
Market News
Biotech
General
From
Benzinga
UK's NICE Rejects Johnson & Johnson's Darzalex Regime For Newly Diagnosed Myeloma
August 30, 2021
Tickers
BMY
JNJ
TAK
TKPHF
Tags
General
Biotech
TKPHF
From
Benzinga
Moderna Withdraws Additional COVID-19 Shots In Japan: What You Need To Know
August 30, 2021
Tickers
MRNA
TAK
TKPHF
Tags
Trading Ideas
Briefs
COVID/19 Coronavirus
From
Benzinga
Suspected Metallic Particles Behind Moderna's Japan COVID-19 Jab Contamination: Reuters
August 27, 2021
Tickers
MRNA
TAK
Tags
MRNA
COVID/19 Vaccine
General
From
Benzinga
Exelixis - Takeda's Cabometyx Scores Approval In Japan For Kidney Cancer
August 26, 2021
Tickers
BMY
EXEL
TAK
TKPHF
Tags
Health Care
Benzinga
Market News
From
Benzinga
Moderna Withdraws 1.6M COVID-19 Vaccine Doses In Japan Over Contamination Concerns
August 26, 2021
Tickers
EBS
JNJ
MRNA
TAK
Tags
JNJ
Covid/19 vaccines
Pandemic
From
Benzinga
Takeda To Lead Finch-Partnered Microbiome IBD Drug
August 10, 2021
Tickers
FNCH
TAK
Tags
Contracts
Health Care
inflammatory bowel disease
From
Benzinga
Why BioCryst Pharmaceuticals Rose 8% on Thursday
August 05, 2021
Tickers
BCRX
TAK
Tags
TAK
Market News
BCRX
From
Motley Fool
Analyzing Takeda Pharmaceutical's Unusual Options Activity
August 03, 2021
Tickers
TAK
Tags
BZI/UOA
TAK
Market News
From
Benzinga
Understanding Takeda Pharmaceutical's Unusual Options Activity
July 30, 2021
Tickers
TAK
Tags
Market News
Benzinga
BZI/TFM
From
Benzinga
Takeda's Narcolepsy Candidate Gets FDA Breakthrough Therapy Tag
July 28, 2021
Tickers
TAK
TKPHF
Tags
FDA
Briefs
Breakthrough Therapy Drug
From
Benzinga
XBIO Stock: Xenetic Soars on Private Placement Announcement
July 26, 2021
Tickers
TAK
XBIO
Tags
NASDAQ:XBIO,NYSE:TAK
Today's Market
Market News
From
InvestorPlace
Is It Too Late to Buy Novavax Stock?
July 26, 2021
Tickers
BNTX
MRNA
NVAX
PFE
Tags
PFE
Market News
TAK
From
Motley Fool
XBIO Stock: Xenetic Soars on Takeda Expansion News
July 23, 2021
Tickers
TAK
XBIO
Tags
Market News
Today's Market
NASDAQ:XBIO,NYSE:TAK
From
InvestorPlace
Moderna Extends Rally With Expanded Japanese COVID-19 Vaccine Supply Deal
July 20, 2021
Tickers
MRNA
TAK
Tags
News
TAK
Japan
From
Benzinga
Japan To Buy Additional 50M Doses Of Moderna COVID-19 Vaccine
July 20, 2021
Tickers
MRNA
TAK
TKPHF
Tags
Benzinga
Market News
Government
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.